30,675 Shares in Axon Enterprise, Inc $AXON Purchased by UNIVEST FINANCIAL Corp

UNIVEST FINANCIAL Corp acquired a new stake in Axon Enterprise, Inc (NASDAQ:AXON) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor acquired 30,675 shares of the biotechnology company’s stock, valued at approximately $12,961,000.

Several other hedge funds and other institutional investors have also made changes to their positions in AXON. NBH Bank raised its position in Axon Enterprise by 5,493.8% during the third quarter. NBH Bank now owns 10,908 shares of the biotechnology company’s stock worth $4,609,000 after acquiring an additional 10,713 shares in the last quarter. First Command Advisory Services Inc. grew its position in shares of Axon Enterprise by 10,431.1% in the 3rd quarter. First Command Advisory Services Inc. now owns 7,793 shares of the biotechnology company’s stock valued at $3,293,000 after acquiring an additional 7,719 shares during the period. Silver Grove Financial Group Inc. grew its position in shares of Axon Enterprise by 21,088.0% in the 3rd quarter. Silver Grove Financial Group Inc. now owns 5,297 shares of the biotechnology company’s stock valued at $2,238,000 after acquiring an additional 5,272 shares during the period. Keybank National Association OH grew its position in shares of Axon Enterprise by 68,460.5% in the 3rd quarter. Keybank National Association OH now owns 698,632 shares of the biotechnology company’s stock valued at $295,186,000 after acquiring an additional 697,613 shares during the period. Finally, Cornerstone Wealth Management LLC increased its stake in shares of Axon Enterprise by 7,632.7% during the 3rd quarter. Cornerstone Wealth Management LLC now owns 57,454 shares of the biotechnology company’s stock worth $24,275,000 after purchasing an additional 56,711 shares during the last quarter. 79.08% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research firms have recently weighed in on AXON. Barclays lowered their price objective on shares of Axon Enterprise from $688.00 to $507.00 and set an “overweight” rating on the stock in a research note on Monday. Northcoast Research raised their target price on shares of Axon Enterprise from $650.00 to $680.00 and gave the company a “buy” rating in a research note on Tuesday, August 11th. Morgan Stanley lifted their price target on Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Piper Sandler reissued an “overweight” rating and set a $540.00 price target (down from $561.00) on shares of Axon Enterprise in a research report on Friday, November 6th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research report on Tuesday, November 3rd. Thirteen research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $612.18.

Axon Enterprise Stock Up 4.3%

AXON opened at $315.42 on Thursday. The stock’s fifty day simple moving average is $426.24 and its 200 day simple moving average is $470.65. Axon Enterprise, Inc has a 1-year low of $291.45 and a 1-year high of $665.07. The stock has a market cap of $25.68 billion, a PE ratio of 101.10, a price-to-earnings-growth ratio of 5.75 and a beta of 1.48. The company has a current ratio of 3.00, a quick ratio of 2.60 and a debt-to-equity ratio of 0.76.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings data on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing analysts’ consensus estimates of $1.89 by ($0.17). Axon Enterprise had a return on equity of 3.87% and a net margin of 7.56%. The company had revenue of $908.55 million for the quarter, compared to the consensus estimate of $934.33 million. During the same period last year, the firm earned $1.17 earnings per share. The company’s revenue for the quarter was up 27.8% compared to the same quarter last year. As a group, research analysts expect that Axon Enterprise, Inc will post 2.10 earnings per share for the current year.

Insider Activity at Axon Enterprise

In related news, President Joshua Isner sold 16,775 shares of Axon Enterprise stock in a transaction dated Monday, August 31st. The shares were sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the sale, the president owned 296,974 shares of the company’s stock, valued at approximately $170,590,774.82. The trade was a 5.35% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Jeffrey C. Kunins sold 9,605 shares of Axon Enterprise stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the sale, the insider directly owned 97,761 shares of the company’s stock, valued at $61,266,818.70. The trade was a 8.95% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 37,397 shares of company stock valued at $21,234,034 over the last three months. Company insiders own 4.20% of the company’s stock.

Key Axon Enterprise News

These are some of the AXON news items that stood out recently:

• Positive Sentiment: Northland maintained a $540 price target despite Axon’s steep decline from its August high, signaling that at least one analyst sees meaningful potential upside. A price target is an estimate, not a guarantee. Axon Is Down 52% From Its August High. Northland Still Sees $540
• Negative Sentiment: Axon’s third-quarter adjusted EPS missed Wall Street expectations, and cautious guidance contributed to a sharp share decline. The company also said federal contract delays shifted $130 million of revenue out of 2026, weighing on near-term expectations. Axon vs. Motorola: Which Public Safety Stock Has More Upside After Q3 Earnings?
• Negative Sentiment: Several law firms have announced investigations into potential securities-law claims related to Axon’s earnings report. These are allegations under investigation, not findings of wrongdoing, but add a source of uncertainty for investors. Levi & Korsinsky investor investigation notice

About Axon Enterprise

Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals. The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.